Literature DB >> 2221966

Prognosis of chronic granulomatous disease.

A Finn1, N Hadzić, G Morgan, S Strobel, R J Levinsky.   

Abstract

The records of 28 patients with chronic granulomatous disease born over a 32 year period were reviewed. The characteristics of the group, and the frequency with which various clinical and laboratory features had been recorded, was assessed. Nine patients were known to have died, in most cases of progressive suppurative infection. Actuarial analysis showed 50% survival through the third decade of life. The long term survival of patients developing symptoms after the end of the first year of life was significantly better than that of patients whose illness started in infancy. Our data confirm that the severity of chronic granulomatous disease is not uniform, and that the prognosis for long term survival is better than that suggested in earlier reports. Early onset may be a poor prognostic sign and invasive aspergillosis is a life threatening complication. In the absence of curative treatment, trials to assess the effectiveness of interferon gamma are necessary and early antenatal diagnosis should be offered to as many affected families as possible.

Entities:  

Mesh:

Year:  1990        PMID: 2221966      PMCID: PMC1792120          DOI: 10.1136/adc.65.9.942

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

1.  Relationship of protein phosphorylation to the activation of the respiratory burst in human neutrophils. Defects in the phosphorylation of a group of closely related 48-kDa proteins in two forms of chronic granulomatous disease.

Authors:  N Okamura; J T Curnutte; R L Roberts; B M Babior
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

2.  Nsi I RFLP at the X-linked chronic granulomatous disease locus (CYBB).

Authors:  L Battat; U Francke
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

3.  Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up.

Authors:  N Kamani; C S August; D E Campbell; N F Hassan; S D Douglas
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

Review 4.  Molecular genetics of chronic granulomatous disease.

Authors:  M C Dinauer; S H Orkin
Journal:  Immunodefic Rev       Date:  1988

5.  Incidence, severity, and prevention of infections in chronic granulomatous disease.

Authors:  R Mouy; A Fischer; E Vilmer; R Seger; C Griscelli
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406

Review 6.  Advantages and disadvantages of antimicrobial prophylaxis in chronic granulomatous disease of childhood.

Authors:  L A Gonzalez; H R Hill
Journal:  Pediatr Infect Dis J       Date:  1988-02       Impact factor: 2.129

7.  The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex.

Authors:  M C Dinauer; S H Orkin; R Brown; A J Jesaitis; C A Parkos
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

8.  Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils.

Authors:  R S Weening; L H Adriaansz; C M Weemaes; R Lutter; D Roos
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

9.  Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.

Authors:  R A Ezekowitz; M C Dinauer; H S Jaffe; S H Orkin; P E Newburger
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

10.  Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.

Authors:  J M Sechler; H L Malech; C J White; J I Gallin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  22 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 2.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

3.  Orofacial findings in chronic granulomatous disease: report of twelve patients and review of the literature.

Authors:  Najla S Dar-Odeh; Wail A Hayajneh; Osama A Abu-Hammad; Huda M Hammad; Adel M Al-Wahadneh; Najwa K Bulos; Azmi M Mahafzah; Maha S Shomaf; Mohammed A El-Maaytah; Faris G Bakri
Journal:  BMC Res Notes       Date:  2010-02-17

4.  Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.

Authors:  Yuka Okura; Masafumi Yamada; Futoshi Kuribayashi; Ichiro Kobayashi; Tadashi Ariga
Journal:  J Clin Immunol       Date:  2015-02-10       Impact factor: 8.317

5.  X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

Authors:  J Rae; P E Newburger; M C Dinauer; D Noack; P J Hopkins; R Kuruto; J T Curnutte
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

6.  Long-term follow-up and prognosis of chronic granulomatous disease in Yugoslavia: is there a role for early bone marrow transplantation?

Authors:  Srdjan Pasic; Aleksandra Minic; Predrag Minic; Dobrila Veljkovic; Desa Lilic; Bojana Slavkovic; Nada Pejnovic; Mario Abinun
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

7.  Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.

Authors:  H Sambatakou; M Guiver; D Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-18       Impact factor: 3.267

8.  Cerebral aspergilloma in a child with autosomal recessive chronic granulomatous disease.

Authors:  A F Dean; I Janota; A Thrasher; I Robertson; G Mieli-Vergani
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

9.  Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.

Authors:  P E Newburger; D G Skalnik; P J Hopkins; E A Eklund; J T Curnutte
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Role of oxygen intermediates in cytotoxicity: studies in chronic granulomatous disease.

Authors:  R L Roberts; B J Ank; M W Fanger; L Shen; E R Stiehm
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.